|
Beiersdorf Aktiengesellschaft / Key word(s): Share Buyback Beiersdorf Aktiengesellschaft: Beiersdorf announces another share buyback program 26-Feb-2025 / 19:39 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News – a service of EQS Group. The issuer is solely responsible for the content of this announcement. Beiersdorf announces another share buyback program
The Executive Board of Beiersdorf Aktiengesellschaft, Hamburg, today resolved – with the approval of the Supervisory Board – to buy back shares in the Company in an amount of up to Euro 500 million also in 2025. This follows the successful completion of the share buyback program in 2024. The share buyback program is expected to begin after the Annual General Meeting 2025 and to be completed by the end of 2025. The Company will announce further details of the share buyback program in accordance with the statutory provisions before the start of the share buyback program. Treasury shares held by the Company will be cancelled to the extent necessary to carry out the share buyback program. Contact: Anke Schmidt End of Inside Information 26-Feb-2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Clearmind Medicine Granted U.S. Patent Approval for Binge Behavior Treatment | Psychedelic Invest
Vancouver, Canada, Aug. 21, 2024 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of
August 22, 2024